These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20129361)

  • 21. Direct stenting in the DES era: Can we do better?
    Bass TA
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):513-4. PubMed ID: 17896409
    [No Abstract]   [Full Text] [Related]  

  • 22. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent.
    Abizaid A; Lansky AJ; Fitzgerald PJ; Tanajura LF; Feres F; Staico R; Mattos L; Abizaid A; Chaves A; Centemero M; Sousa AG; Sousa JE; Zaugg MJ; Schwartz LB
    Am J Cardiol; 2007 May; 99(10):1403-8. PubMed ID: 17493469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies.
    Steinberg DH; Mintz GS; Mandinov L; Yu A; Ellis SG; Grube E; Dawkins KD; Ormiston J; Turco MA; Stone GW; Weissman NJ
    JACC Cardiovasc Interv; 2010 May; 3(5):486-94. PubMed ID: 20488404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
    Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stent thrombosis after complex multivessel stenting in an elderly patient.
    Ito S; Yoshida T
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):299-303. PubMed ID: 20665881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular ultrasound for assessment of coronary drug-eluting stent deployment: an evolving field in need of new criteria.
    Eshtehardi P; Samady H
    JACC Cardiovasc Interv; 2010 Mar; 3(3):364. PubMed ID: 20299000
    [No Abstract]   [Full Text] [Related]  

  • 28. Extremely late drug-eluting stent thrombosis: 2037 days after deployment.
    Layland J; Jellis C; Whitbourn R
    Cardiovasc Revasc Med; 2009; 10(1):55-7. PubMed ID: 19159856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial.
    Chevalier B; Di Mario C; Neumann FJ; Ribichini F; Urban P; Popma JJ; Fitzgerald PJ; Cutlip DE; Williams DO; Ormiston J; Grube E; Whitbourn R; Schwartz LB;
    JACC Cardiovasc Interv; 2008 Oct; 1(5):524-32. PubMed ID: 19463354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple stent fractures at the site of coronary artery bypass insertion.
    Hetterich H; Rieber J
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):84-7. PubMed ID: 19089946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Very late thrombosis of paclitaxel-eluting stent.
    Aytekin V; Erdim R; Gormez S; Demiroglu C
    Cardiovasc Revasc Med; 2008; 9(4):275-7. PubMed ID: 18928954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atheromatous degeneration of the neointima in a bare metal stent: intravascular ultrasound evidence.
    Fineschi M; Carrera A; Gori T
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):572-3. PubMed ID: 19444133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis.
    Alfonso F; Dutary J; Paulo M; Gonzalo N; Pérez-Vizcayno MJ; Jiménez-Quevedo P; Escaned J; Bañuelos C; Hernández R; Macaya C
    Heart; 2012 Aug; 98(16):1213-20. PubMed ID: 22826559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravascular ultrasound assessment of sirolimus-eluting stent restenosis or thrombosis after stent implantation].
    Liu XB; Qian JY; Zhang F; Ge L; Huang D; Fan B; Wang QB; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 May; 37(5):397-401. PubMed ID: 19781212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A ticking time bomb?: a case report of very late stent thrombosis more than 2 years after fracture of a Cypher stent.
    Ong SH; Mueller R; Boekstegers P
    Clin Res Cardiol; 2011 Oct; 100(10):951-3. PubMed ID: 21725857
    [No Abstract]   [Full Text] [Related]  

  • 36. Preliminary results of the hydroxyapatite nonpolymer-based sirolimus-eluting stent for the treatment of single de novo coronary lesions a first-in-human analysis of a third-generation drug-eluting stent system.
    Costa JR; Abizaid A; Costa R; Feres F; Tanajura LF; Abizaid A; Mattos LA; Staico R; Siqueira D; Sousa AG; Bonan R; Sousa JE
    JACC Cardiovasc Interv; 2008 Oct; 1(5):545-51. PubMed ID: 19463357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
    Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
    Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
    [No Abstract]   [Full Text] [Related]  

  • 38. Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial.
    Leon MB; Nikolsky E; Cutlip DE; Mauri L; Liberman H; Wilson H; Patterson J; Moses J; Kandzari DE;
    JACC Cardiovasc Interv; 2010 Oct; 3(10):1043-50. PubMed ID: 20965463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
    Uchida T; Popma J; Stone GW; Ellis SG; Turco MA; Ormiston JA; Muramatsu T; Nakamura M; Nanto S; Yokoi H; Baim DS
    JACC Cardiovasc Interv; 2010 Apr; 3(4):403-11. PubMed ID: 20398868
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stent expansion as a mechanical parameter to predict late stent patency: back to the basics.
    Honda Y; Fitzgerald PJ
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1276-8. PubMed ID: 20129556
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.